159 related articles for article (PubMed ID: 28629825)
21. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
Peng W; Wu J; Feng J
Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
24. Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90.
Kuai Y; Gong X; Ding L; Li F; Lei L; Gong Y; Liu Q; Tan H; Zhang X; Liu D; Ren G; Pan H; Shi Y; Berberich-Siebelt F; Mao Z; Zhou R
Cell Commun Signal; 2018 Aug; 16(1):50. PubMed ID: 30143009
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
[TBL] [Abstract][Full Text] [Related]
27. Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
Lao X; Feng Q; He G; Ji M; Zhu D; Xu P; Tang W; Xu J; Qin X
Ann Surg Oncol; 2016 Nov; 23(12):3924-3933. PubMed ID: 27411551
[TBL] [Abstract][Full Text] [Related]
28. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
[TBL] [Abstract][Full Text] [Related]
29. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
30. β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma.
Cai N; Chen Z; Huang Y; Shao S; Yu H; Wang Y; He S
Cancer Biol Ther; 2020; 21(3):241-247. PubMed ID: 31731887
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
Peng W; Fan H; Wu G; Wu J; Feng J
Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
[TBL] [Abstract][Full Text] [Related]
32. miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.
Tao Y; Song Y; Han T; Wang C; Zhao T; Gu Y
Biomed Pharmacother; 2017 Dec; 96():191-197. PubMed ID: 28987942
[TBL] [Abstract][Full Text] [Related]
33. ICT1 Promotes Osteosarcoma Cell Proliferation and Inhibits Apoptosis via STAT3/BCL-2 Pathway.
Pan X; Tan J; Weng X; Du R; Jiang Y; Weng Y; Zhou D; Shen Y
Biomed Res Int; 2021; 2021():8971728. PubMed ID: 33585660
[TBL] [Abstract][Full Text] [Related]
34. Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells.
Xi M; He W; Li B; Zhou J; Xu Z; Wu H; Zhang Y; Song D; Hu L; Lu Y; Bu W; Kong Y; Chen G; Chang S; Shi J; Zhu W
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):401-410. PubMed ID: 32259210
[TBL] [Abstract][Full Text] [Related]
35. Palbociclib enhances the effect of doxorubicin-induced apoptosis in activated B-cell-like diffuse large B-cell lymphoma cells.
Yi L; Hu L; Huang K; Li Q; Wang Y; Wang J; Zhai Z
Anticancer Drugs; 2023 Feb; 34(2):257-268. PubMed ID: 36206105
[TBL] [Abstract][Full Text] [Related]
36. A novel benzoxazinone derivative YLT-LL-11 inhibits diffuse large B-cell lymphoma growth via inducing cell cycle arrest and apoptosis.
Peng C; Sun C; Wang N; He Y; Xu J; Deng Y; Gao L; Zhong J; Xiong X; Liu L
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31527063
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY
Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973
[TBL] [Abstract][Full Text] [Related]
38. CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma.
Li Y; Zhou X; Zhang Y; Yang J; Xu Y; Zhao Y; Wang X
Cell Cycle; 2019 Feb; 18(4):379-394. PubMed ID: 30612524
[TBL] [Abstract][Full Text] [Related]
39. [Progress of study on survivin in diffuse large B-cell lymphoma--review].
Dou HJ; Hu JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1487-90. PubMed ID: 19099670
[TBL] [Abstract][Full Text] [Related]
40. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]